During the past decade, LeBauer Cardiovascular Research Foundation conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 9 clinical trials were completed, i.e. on average, 450% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "LeBauer Cardiovascular Research Foundation" #1 sponsor was "Boston Scientific Corporation" with 9 trials, followed by "Pfizer" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Arginox Pharmaceuticals" with 1 trials sponsored and "Biosensors Europe SA" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "LeBauer Cardiovascular Research Foundation" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "Cardialysis BV" with 1 trials as a collaborator and "Dickson Advanced Analytics Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "LeBauer Cardiovascular Research Foundation" are "Coronary Artery Disease" (10 trials), "Acute Coronary Syndrome" (2 trials), "Cardiovascular Disease" (2 trials), "Heart Failure" (2 trials) and "Acute Decompensation of Chronic Heart Failure" (1 trials). Many other conditions were trialed in "LeBauer Cardiovascular Research Foundation" in a lesser frequency.

Most popular intervention types in "LeBauer Cardiovascular Research Foundation" are "Device" (15 trials), "Drug" (13 trials), "Procedure" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "PROMUS Element Coronary Stent System" (3 trials), "Aspirin" (2 trials), "Thienopyridine" (2 trials) and "Unfractionated Heparin" (2 trials). Other intervention names were less common.

The vast majority of trials in "LeBauer Cardiovascular Research Foundation" are 26 trials for "All" genders.

Currently, there are NaN active trials in "LeBauer Cardiovascular Research Foundation". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in LeBauer Cardiovascular Research Foundation, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in LeBauer Cardiovascular Research Foundation, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".